# Fly-E Group, Inc.: financial statements, quarterly

FLYE · Nasdaq · CIK 1975940 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/flye.md) · [Financials](/companies/flye/financials.md) · [Filings](/companies/flye/filings.md) · [Insiders](/companies/flye/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/flye/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [8,764](/filings/0001213900-24-100200.md) | [7,428](/filings/0001213900-25-015334.md) | [8,171 d](/filings/0001213900-25-064293.md) | [7,873](/filings/0001213900-25-078571.md) | [6,824](/filings/0001213900-25-123281.md) | [5,678](/filings/0001213900-26-046242.md) | [5,051 d](/filings/0001213900-26-080973.md) | [5,328](/filings/0001213900-26-096305.md) | [3,909](/filings/0001213900-25-123281.md) | [2,649](/filings/0001213900-26-046242.md) | [7,177 d](/filings/0001213900-26-080973.md) | [2,748](/filings/0001213900-26-096305.md) |
| Cost of revenue | $k | [5,003](/filings/0001213900-24-100200.md) | [4,455](/filings/0001213900-25-015334.md) | [4,522 d](/filings/0001213900-25-064293.md) | [4,774](/filings/0001213900-25-078571.md) | [3,920](/filings/0001213900-25-123281.md) | [3,117](/filings/0001213900-26-046242.md) | [3,166 d](/filings/0001213900-26-080973.md) | [3,067](/filings/0001213900-26-096305.md) | [2,932](/filings/0001213900-25-123281.md) | [1,601](/filings/0001213900-26-046242.md) | [6,805 d](/filings/0001213900-26-080973.md) | [2,448](/filings/0001213900-26-096305.md) |
| Gross profit | $k | [3,761](/filings/0001213900-24-100200.md) | [2,973](/filings/0001213900-25-015334.md) | [3,650 d](/filings/0001213900-25-064293.md) | [3,100](/filings/0001213900-25-078571.md) | [2,904](/filings/0001213900-25-123281.md) | [2,561](/filings/0001213900-26-046242.md) | [1,886 d](/filings/0001213900-26-080973.md) | [2,261](/filings/0001213900-26-096305.md) | [977](/filings/0001213900-25-123281.md) | [1,049](/filings/0001213900-26-046242.md) | [373 d](/filings/0001213900-26-080973.md) | [300](/filings/0001213900-26-096305.md) |
| Research and development | $k | [7.5](/filings/0001213900-24-100200.md) | [89.4](/filings/0001213900-25-015334.md) | [196 d](/filings/0001213900-25-064293.md) | [146](/filings/0001213900-24-070250.md) | [164](/filings/0001213900-24-100200.md) | [125](/filings/0001213900-25-015334.md) | [115 d](/filings/0001213900-26-080973.md) | [169](/filings/0001213900-26-096305.md) | not reported | not reported | not reported | [1,800](/filings/0001213900-26-096305.md) |
| Operating income | $k | [1,085](/filings/0001213900-24-100200.md) | [194](/filings/0001213900-25-015334.md) | [1,214 d](/filings/0001213900-25-064293.md) | [(45.5)](/filings/0001213900-25-078571.md) | [(1,231)](/filings/0001213900-25-123281.md) | [(940)](/filings/0001213900-26-046242.md) | [(2,343) d](/filings/0001213900-26-080973.md) | [(1,505)](/filings/0001213900-26-096305.md) | [(1,048)](/filings/0001213900-25-123281.md) | [(1,557)](/filings/0001213900-26-046242.md) | [(2,328) d](/filings/0001213900-26-080973.md) | [(3,536)](/filings/0001213900-26-096305.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [546](/filings/0001213900-26-096305.md) | not reported | not reported | not reported | [191](/filings/0001213900-26-096305.md) |
| Income tax | $k | [361](/filings/0001213900-24-100200.md) | [87.7](/filings/0001213900-25-015334.md) | [451 d](/filings/0001213900-25-064293.md) | [72.4](/filings/0001213900-25-078571.md) | [(166)](/filings/0001213900-25-123281.md) | [(428)](/filings/0001213900-26-046242.md) | [858 d](/filings/0001213900-26-080973.md) | [(50.3)](/filings/0001213900-26-096305.md) | [40.0](/filings/0001213900-25-123281.md) | [(150)](/filings/0001213900-26-046242.md) | [489 d](/filings/0001213900-26-080973.md) | [89.0](/filings/0001213900-26-096305.md) |
| Net income | $k | [747](/filings/0001213900-25-015334.md) | [20.9](/filings/0001213900-25-015334.md) | [687 d](/filings/0001213900-25-064293.md) | [(180)](/filings/0001213900-26-046242.md) | [(1,143)](/filings/0001213900-26-046242.md) | [(684)](/filings/0001213900-26-046242.md) | [(3,284) d](/filings/0001213900-26-080973.md) | [(2,009)](/filings/0001213900-26-096305.md) | [(1,776)](/filings/0001213900-26-046242.md) | [(1,923)](/filings/0001213900-26-046242.md) | [(3,550) d](/filings/0001213900-26-080973.md) | [(3,939)](/filings/0001213900-26-096305.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [(2.78)](/filings/0001213900-26-046242.md) | not reported | [(6.00)](/filings/0001213900-26-096305.md) | not reported | [(1.18)](/filings/0001213900-26-046242.md) | not reported | [(2.41)](/filings/0001213900-26-096305.md) |
| Basic EPS | $ per share | [0.03](/filings/0001213900-24-100200.md) | [0.00](/filings/0001213900-25-015334.md) | not reported | [(0.04)](/filings/0001213900-25-078571.md) | [(4.65)](/filings/0001213900-25-123281.md) | [(2.78)](/filings/0001213900-26-046242.md) | not reported | [(6.00)](/filings/0001213900-26-096305.md) | [(2.18)](/filings/0001213900-25-123281.md) | [(1.18)](/filings/0001213900-26-046242.md) | not reported | [(2.41)](/filings/0001213900-26-096305.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | period not labelled (2024-12-17) | Q3 FY2025 (2024-12-31) | period not labelled (2025-03-11) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.4](/filings/0001213900-25-064293.md) | [4.5](/filings/0001213900-24-070250.md) | [1.3](/filings/0001213900-24-100200.md) | [0.6](/filings/0001213900-25-064293.md) | [1.4](/filings/0001213900-25-015334.md) | [0.3](/filings/0001213900-25-064293.md) | [0.8](/filings/0001213900-25-123281.md) | [2.3](/filings/0001213900-25-078571.md) | [2.5](/filings/0001213900-25-123281.md) | not reported | not reported | not reported |
| Current assets | $m | [8.1](/filings/0001213900-25-064293.md) | [13.9](/filings/0001213900-24-070250.md) | [13.2](/filings/0001213900-24-100200.md) | not reported | [12.8](/filings/0001213900-25-015334.md) | not reported | [14.0](/filings/0001213900-26-080973.md) | [16.8](/filings/0001213900-25-078571.md) | [16.8](/filings/0001213900-25-123281.md) | [20.7](/filings/0001213900-26-046242.md) | [16.8](/filings/0001213900-26-096305.md) | [16.1](/filings/0001213900-26-096305.md) |
| Total assets | $m | [29.0](/filings/0001213900-25-064293.md) | [35.2](/filings/0001213900-24-070250.md) | [38.2](/filings/0001213900-24-100200.md) | not reported | [37.2](/filings/0001213900-25-015334.md) | not reported | [33.7](/filings/0001213900-26-080973.md) | [33.8](/filings/0001213900-25-078571.md) | [31.6](/filings/0001213900-25-123281.md) | [34.0](/filings/0001213900-26-046242.md) | [29.5](/filings/0001213900-26-096305.md) | [26.2](/filings/0001213900-26-096305.md) |
| Current liabilities | $m | [7.8](/filings/0001213900-25-064293.md) | [6.2](/filings/0001213900-24-070250.md) | [10.9](/filings/0001213900-24-100200.md) | not reported | [9.9](/filings/0001213900-25-015334.md) | not reported | [12.7](/filings/0001213900-26-080973.md) | [10.7](/filings/0001213900-25-078571.md) | [8.6](/filings/0001213900-25-123281.md) | [7.3](/filings/0001213900-26-046242.md) | [6.8](/filings/0001213900-26-096305.md) | [8.0](/filings/0001213900-26-096305.md) |
| Total liabilities | $m | [22.2](/filings/0001213900-25-064293.md) | [20.2](/filings/0001213900-24-070250.md) | [24.3](/filings/0001213900-24-100200.md) | not reported | [24.1](/filings/0001213900-25-015334.md) | not reported | [23.9](/filings/0001213900-26-080973.md) | [20.1](/filings/0001213900-25-078571.md) | [16.3](/filings/0001213900-25-123281.md) | [13.0](/filings/0001213900-26-046242.md) | [12.1](/filings/0001213900-26-096305.md) | [12.7](/filings/0001213900-26-096305.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001213900-25-078571.md) | [0.2](/filings/0001213900-25-123281.md) | [0.1](/filings/0001213900-26-046242.md) | [6.0](/filings/0001213900-26-080973.md) | [5.9](/filings/0001213900-26-096305.md) |
| Current portion of debt | $m | [1.2](/filings/0001213900-25-064293.md) | [1.1](/filings/0001213900-24-070250.md) | [0.1](/filings/0001213900-24-100200.md) | not reported | [0.1](/filings/0001213900-25-015334.md) | not reported | [0.1](/filings/0001213900-26-080973.md) | [0.3](/filings/0001213900-25-078571.md) | [0.2](/filings/0001213900-25-123281.md) | [0.1](/filings/0001213900-26-046242.md) | [0.1](/filings/0001213900-26-096305.md) | [0.1](/filings/0001213900-26-096305.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [5.2](/filings/0001213900-25-123281.md) | [6.3](/filings/0001213900-25-078571.md) | [5.5](/filings/0001213900-25-123281.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [6.8](/filings/0001213900-26-080973.md) | [15.0](/filings/0001213900-26-046242.md) | [13.8](/filings/0001213900-26-046242.md) | not reported | [13.1](/filings/0001213900-26-046242.md) | not reported | [9.8](/filings/0001213900-26-096305.md) | [13.7](/filings/0001213900-26-096305.md) | [15.3](/filings/0001213900-26-046242.md) | [21.0](/filings/0001213900-26-046242.md) | [17.4](/filings/0001213900-26-096305.md) | [13.5](/filings/0001213900-26-096305.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [774 d](/filings/0001213900-24-100200.md) | [150 d](/filings/0001213900-25-015334.md) | [2,565 d](/filings/0001213900-25-064293.md) | [(4,522)](/filings/0001213900-25-078571.md) | [(4,890) d](/filings/0001213900-25-123281.md) | [(1.8) d](/filings/0001213900-26-046242.md) | [(645) d](/filings/0001213900-26-080973.md) | [(5,284)](/filings/0001213900-26-096305.md) | [(2,423) d](/filings/0001213900-25-123281.md) | [(6,264) d](/filings/0001213900-26-046242.md) | [121 d](/filings/0001213900-26-080973.md) | [(190)](/filings/0001213900-26-096305.md) |
| Capital expenditure | $k | [136 d](/filings/0001213900-24-100200.md) | [(22.4) d](/filings/0001213900-25-015334.md) | [750 d](/filings/0001213900-25-064293.md) | [352](/filings/0001213900-25-078571.md) | [1,224 d](/filings/0001213900-25-123281.md) | [42.4 d](/filings/0001213900-26-046242.md) | [15.9 d](/filings/0001213900-26-080973.md) | [142](/filings/0001213900-26-096305.md) | [(97.0) d](/filings/0001213900-25-123281.md) | [25.2 d](/filings/0001213900-26-046242.md) | [4.8 d](/filings/0001213900-26-080973.md) | [2.2](/filings/0001213900-26-096305.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.0](/filings/0001213900-24-070250.md) | [22.0](/filings/0001213900-24-100200.md) | [22.0](/filings/0001213900-25-015334.md) | [4.5](/filings/0001213900-25-078571.md) | [0.2](/filings/0001213900-25-123281.md) | [0.2](/filings/0001213900-26-046242.md) | [0.3](/filings/0001213900-26-096305.md) | [0.8](/filings/0001213900-25-123281.md) | [1.6](/filings/0001213900-26-046242.md) | [1.6](/filings/0001213900-26-096305.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,632,386 at 2026-09-01, from the cover of the [10-Q filed 2026-09-01](/filings/0001213900-26-096305.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.